Khalid Farah, Bushra Rabia, Ghayas Sana, Mushtaque Madiha
Department of Pharmacy Practice, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan.
Department of Pharmaceutics, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan.
Clin Med Insights Case Rep. 2022 Jul 21;15:11795476221112819. doi: 10.1177/11795476221112819. eCollection 2022.
Urinary tract infection (UTI) is caused by bacteria growing in urine and affect kidneys, bladder, ureters, and urethra. Women with diabetes are at high risk of developing UTI. This is a case of a 60-year-old postmenopausal woman with uncontrolled type-I diabetes mellitus and hypertension, who presented with an acute onset of dysuria, burning micturition, and increased frequency. This case highlights the shortfall in the preliminary management plan of performing imperative clinical laboratory investigations including urine detailed report (DR), urine culture and sensitivity(C/S), and plasma glucose testing to initiate antimicrobial treatment. UTI requires to be treated precisely in diabetic patients with the help of a comprehensive diagnosis for signs of dysuria, frequent urination, and pelvic pain. The treatment of UTIs should always begin with culture and sensitivity analysis while the patient is symptomatic, to initiate antimicrobial treatment. Comorbidities should be managed appropriately during treatment to achieve desired therapeutic outcomes.
尿路感染(UTI)是由尿液中生长的细菌引起的,会影响肾脏、膀胱、输尿管和尿道。糖尿病女性患UTI的风险很高。这是一例60岁的绝经后女性病例,患有未控制的I型糖尿病和高血压,出现了排尿困难、尿痛和尿频的急性发作。该病例凸显了在进行必要的临床实验室检查(包括尿液详细报告(DR)、尿培养和药敏试验(C/S)以及血浆葡萄糖检测)以启动抗菌治疗的初步管理计划中的不足。在糖尿病患者中,需要借助对排尿困难、尿频和盆腔疼痛症状的全面诊断来精确治疗UTI。在患者出现症状时,UTI的治疗应始终从培养和药敏分析开始,以启动抗菌治疗。在治疗期间应适当管理合并症,以实现理想的治疗效果。